Influence of the treatment facility volume on the survival of patients with non‐Hodgkin lymphoma
Open Access
Abstract
BACKGROUND: Prior studies have shown that a higher hospital volume or physician caseload is associated with better outcomes for complex and uncommon surgical procedures. Similar studies in the medical management of rare diseases such as hematologic cancers are limited. This retrospective, observational study using the US National Cancer Data Base determined the extent to which the number of new non‐Hodgkin lymphoma (NHL) patients treated annually at a treatment facility affected overall survival (OS).METHODS: There were 278,985 patients treated at 1151 facilities from 1998 to 2006. Treatment facilities were classified by quartiles based on the average number of new NHL patients seen annually: quartile 1 (Q1), 2 to 13 patients; quartile 2 (Q2), 14 to 20 patients; quartile 3 (Q3), 21 to 32 patients; and quartile 4 (Q4), 33 or more patients. The outcome of interest was OS according to facility volume.RESULTS: The unadjusted median OS was 61.8 months for Q1, 65.9 months for Q2, 71.4 months for Q3, and 83.6 months for Q4. A multivariate analysis that was adjusted for demographic (sex, age, race, and ethnicity), socioeconomic (income and insurance type), geographic (area of residence), disease‐specific (NHL subtype and stage), and facility‐specific factors (type and location) showed that the facility volume was associated with OS. Compared with patients at Q4 facilities, patients at lower quartile facilities had higher mortality (hazard ratio for Q3, 1.05 [95% confidence interval, 1.04‐1.06]; hazard ratio for Q2, 1.08 [95% confidence interval, 1.07‐1.10]; hazard ratio for Q1, 1.14 [95% confidence interval, 1.11‐1.17]).CONCLUSIONS: NHL patients treated at higher volume facilities may survive longer than those treated at lower volume facilities. Further work is needed to understand the mechanisms of these differences and whether volume should be considered in the determination of referrals for NHL patients. Cancer 2016;122:2552–9. © 2016 American Cancer Society.Keywords
This publication has 23 references indexed in Scilit:
- Tracking the Workforce: The American Society of Clinical Oncology Workforce Information SystemJournal of Oncology Practice, 2013
- Adherence to Stage-Specific Treatment Guidelines for Patients With Colon CancerJournal of Clinical Oncology, 2012
- Who Receives Their Complex Cancer Surgery at Low-Volume Hospitals?Journal of the American College of Surgeons, 2012
- A Decade of Mortality Reductions in Major Oncologic SurgeryMedical Care, 2010
- The Organization of Multidisciplinary Care Teams: Modeling Internal and External Influences on Cancer Care QualityJNCI Monographs, 2010
- Survival Disparities in Patients With Lymphoma According to Place of Residence and Treatment Provider: A Population-Based StudyJournal of Clinical Oncology, 2009
- The Effect of Provider Case Volume on Cancer Mortality: Systematic Review and Meta-AnalysisCA: A Cancer Journal for Clinicians, 2009
- Relation of Surgeon and Hospital Volume to Processes and Outcomes of Colorectal Cancer SurgeryAnnals of Surgery, 2006
- Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United StatesBlood, 2005
- Adapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJournal of Clinical Epidemiology, 1992